Global HMO Infant Formula Market Growth 2025-2031

Publication ID:

LPI04259824

Publication Date:

April 16, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Retailing [2]

Consumer & Retail [3]

Description:

The global HMO Infant Formula market size is predicted to grow from US$ 4144 million in 2025 to US$ 7849 million in 2031; it is expected to grow at a CAGR of 11.2% from 2025 to 2031.
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Global key players of HMO Infant Formula include Nestl茅 (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.
The 鈥淗MO Infant Formula Industry Forecast鈥� looks at past sales and reviews total world HMO Infant Formula sales in 2024, providing a comprehensive analysis by region and market sector of projected HMO Infant Formula sales for 2025 through 2031. With HMO Infant Formula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HMO Infant Formula industry.
This Insight Report provides a comprehensive analysis of the global HMO Infant Formula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HMO Infant Formula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global HMO Infant Formula market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HMO Infant Formula and breaks down the forecast by Type, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HMO Infant Formula.
This report presents a comprehensive overview, market shares, and growth opportunities of HMO Infant Formula market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
2'-Fucosyllactose (2'-FL)
Others
Segmentation by Sales Channel:
Online Channel
Specialty Store
Supermarket
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Mead Johnson锛圧eckitt锛�
Nestl茅锛圵yeth Nutrition锛�
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)
Key Questions Addressed in this Report
What is the 10-year outlook for the global HMO Infant Formula market?
What factors are driving HMO Infant Formula market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HMO Infant Formula market opportunities vary by end market size?
How does HMO Infant Formula break out by Type, by Sales Channel?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HMO Infant Formula Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for HMO Infant Formula by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for HMO Infant Formula by Country/Region, 2020, 2024 & 2031
2.2 HMO Infant Formula Segment by Type
2.2.1 2'-Fucosyllactose (2'-FL)
2.2.2 Others
2.3 HMO Infant Formula Sales by Type
2.3.1 Global HMO Infant Formula Sales Market Share by Type (2020-2025)
2.3.2 Global HMO Infant Formula Revenue and Market Share by Type (2020-2025)
2.3.3 Global HMO Infant Formula Sale Price by Type (2020-2025)
2.4 HMO Infant Formula Segment by Sales Channel
2.4.1 Online Channel
2.4.2 Specialty Store
2.4.3 Supermarket
2.4.4 Others
2.5 HMO Infant Formula Sales by Sales Channel
2.5.1 Global HMO Infant Formula Sale Market Share by Sales Channel (2020-2025)
2.5.2 Global HMO Infant Formula Revenue and Market Share by Sales Channel (2020-2025)
2.5.3 Global HMO Infant Formula Sale Price by Sales Channel (2020-2025)
3 Global by Company
3.1 Global HMO Infant Formula Breakdown Data by Company
3.1.1 Global HMO Infant Formula Annual Sales by Company (2020-2025)
3.1.2 Global HMO Infant Formula Sales Market Share by Company (2020-2025)
3.2 Global HMO Infant Formula Annual Revenue by Company (2020-2025)
3.2.1 Global HMO Infant Formula Revenue by Company (2020-2025)
3.2.2 Global HMO Infant Formula Revenue Market Share by Company (2020-2025)
3.3 Global HMO Infant Formula Sale Price by Company
3.4 Key Manufacturers HMO Infant Formula Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HMO Infant Formula Product Location Distribution
3.4.2 Players HMO Infant Formula Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for HMO Infant Formula by Geographic Region
4.1 World Historic HMO Infant Formula Market Size by Geographic Region (2020-2025)
4.1.1 Global HMO Infant Formula Annual Sales by Geographic Region (2020-2025)
4.1.2 Global HMO Infant Formula Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic HMO Infant Formula Market Size by Country/Region (2020-2025)
4.2.1 Global HMO Infant Formula Annual Sales by Country/Region (2020-2025)
4.2.2 Global HMO Infant Formula Annual Revenue by Country/Region (2020-2025)
4.3 Americas HMO Infant Formula Sales Growth
4.4 APAC HMO Infant Formula Sales Growth
4.5 Europe HMO Infant Formula Sales Growth
4.6 Middle East & Africa HMO Infant Formula Sales Growth
5 Americas
5.1 Americas HMO Infant Formula Sales by Country
5.1.1 Americas HMO Infant Formula Sales by Country (2020-2025)
5.1.2 Americas HMO Infant Formula Revenue by Country (2020-2025)
5.2 Americas HMO Infant Formula Sales by Type (2020-2025)
5.3 Americas HMO Infant Formula Sales by Sales Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HMO Infant Formula Sales by Region
6.1.1 APAC HMO Infant Formula Sales by Region (2020-2025)
6.1.2 APAC HMO Infant Formula Revenue by Region (2020-2025)
6.2 APAC HMO Infant Formula Sales by Type (2020-2025)
6.3 APAC HMO Infant Formula Sales by Sales Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe HMO Infant Formula by Country
7.1.1 Europe HMO Infant Formula Sales by Country (2020-2025)
7.1.2 Europe HMO Infant Formula Revenue by Country (2020-2025)
7.2 Europe HMO Infant Formula Sales by Type (2020-2025)
7.3 Europe HMO Infant Formula Sales by Sales Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HMO Infant Formula by Country
8.1.1 Middle East & Africa HMO Infant Formula Sales by Country (2020-2025)
8.1.2 Middle East & Africa HMO Infant Formula Revenue by Country (2020-2025)
8.2 Middle East & Africa HMO Infant Formula Sales by Type (2020-2025)
8.3 Middle East & Africa HMO Infant Formula Sales by Sales Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HMO Infant Formula
10.3 Manufacturing Process Analysis of HMO Infant Formula
10.4 Industry Chain Structure of HMO Infant Formula
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HMO Infant Formula Distributors
11.3 HMO Infant Formula Customer
12 World Forecast Review for HMO Infant Formula by Geographic Region
12.1 Global HMO Infant Formula Market Size Forecast by Region
12.1.1 Global HMO Infant Formula Forecast by Region (2026-2031)
12.1.2 Global HMO Infant Formula Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global HMO Infant Formula Forecast by Type (2026-2031)
12.7 Global HMO Infant Formula Forecast by Sales Channel (2026-2031)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott HMO Infant Formula Product Portfolios and Specifications
13.1.3 Abbott HMO Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Mead Johnson锛圧eckitt锛�
13.2.1 Mead Johnson锛圧eckitt锛� Company Information
13.2.2 Mead Johnson锛圧eckitt锛� HMO Infant Formula Product Portfolios and Specifications
13.2.3 Mead Johnson锛圧eckitt锛� HMO Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mead Johnson锛圧eckitt锛� Main Business Overview
13.2.5 Mead Johnson锛圧eckitt锛� Latest Developments
13.3 Nestl茅锛圵yeth Nutrition锛�
13.3.1 Nestl茅锛圵yeth Nutrition锛� Company Information
13.3.2 Nestl茅锛圵yeth Nutrition锛� HMO Infant Formula Product Portfolios and Specifications
13.3.3 Nestl茅锛圵yeth Nutrition锛� HMO Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Nestl茅锛圵yeth Nutrition锛� Main Business Overview
13.3.5 Nestl茅锛圵yeth Nutrition锛� Latest Developments
13.4 Danone (Aptamil)
13.4.1 Danone (Aptamil) Company Information
13.4.2 Danone (Aptamil) HMO Infant Formula Product Portfolios and Specifications
13.4.3 Danone (Aptamil) HMO Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Danone (Aptamil) Main Business Overview
13.4.5 Danone (Aptamil) Latest Developments
13.5 FrieslandCampina (Friso)
13.5.1 FrieslandCampina (Friso) Company Information
13.5.2 FrieslandCampina (Friso) HMO Infant Formula Product Portfolios and Specifications
13.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 FrieslandCampina (Friso) Main Business Overview
13.5.5 FrieslandCampina (Friso) Latest Developments
13.6 Biostime
13.6.1 Biostime Company Information
13.6.2 Biostime HMO Infant Formula Product Portfolios and Specifications
13.6.3 Biostime HMO Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Biostime Main Business Overview
13.6.5 Biostime Latest Developments
13.7 Yili Group (Ausnutria Dairy)
13.7.1 Yili Group (Ausnutria Dairy) Company Information
13.7.2 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolios and Specifications
13.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Yili Group (Ausnutria Dairy) Main Business Overview
13.7.5 Yili Group (Ausnutria Dairy) Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂